...
首页> 外文期刊>Medical Physics >Verification of MLC based real-time tumor tracking using an electronic portal imaging device.
【24h】

Verification of MLC based real-time tumor tracking using an electronic portal imaging device.

机译:使用电子门禁成像设备验证基于MLC的实时肿瘤追踪。

获取原文
获取原文并翻译 | 示例

摘要

PURPOSE: The authors have developed a novel technique using an electronic portal imaging device (EPID) to verify the geometrical accuracy of delivery of dose-rate-regulated tracking (DRRT). This technique, called verification of real-time tracking with EPID (VORTE), can potentially be used for both on-line and off-line quality assurance (QA) of MLC-based dynamic tumor tracking. METHODS: The shape and position of target as a function of time, which is assumed to be known, is projected onto the EPID plane. This projected sequence of apertures as a function of time (target motion) is then used as the reference. The accuracy of dynamic MLC tracking can then be assessed by how well the delivered beam follows this projected target motion without the use of a physical moving phantom. The beam apertures controlled by DRRT (aperture motion) is detected by the EPID as a function of time. The aperture motion is compared to the target motion to evaluate tracking error introduced by DRRT. The accuracy of VORTE was measured using film measurements of ten static fields. The VORTE for dynamic tumor tracking was tested with several target motions, including (1) rigid-body two-dimensional (2-D) cyclic motion in the superior-inferior direction with various period and amplitude; (2) the above 2-D cyclic motion plus cyclic deformation; and (3) 2-D cyclic motion with both deformation and rotation. For each target motion, the controlled aperture motion resulting from DRRT was acquired at approximately 8 Hz using EPID in the continuous-acquisition mode. Leaf positions in all captured frames were measured from the EPID and compared to their expected positions. The passing rate of 2 mm criteria for all leaves from all frames was calculated for each of the four patterns of tumor motion. Additionally, the root-mean-square (RMS) deviations of the centroid of the apertures between the designed and delivered beams were calculated for all three cases. RESULTS: The accuracy of MLC-leaf position determination by VORTE is 0.5 mm (1 standard deviation) by comparison to film measurements. With DRRT, the passing rates using the 2 mm criteria for all acquired frames are 100% for the 2-D displacement, 99% for the 2-D displacement with deformation, and 88% for the 2-D displacement combined with both deformation and rotation. The RMS deviations are 0.6 mm for the 2-D displacement, 1.0 mm for the 2-D displacement with deformation, and 1.1 mm for the 2-D displacement combined with both deformation and rotation. CONCLUSIONS: The VORTE can measure the accuracy of MLC-based tumor tracking without the necessity of employing a moving phantom. Moreover, it can be used for complex target motion (i.e., 2-D displacement combined with deformation and rotation) that is difficult to create with physical moving phantoms. Therefore, the VORTE and the novel QA process illustrated by this study have a great potential for verifying real-time tumor tracking.
机译:目的:作者开发了一种使用电子门禁成像设备(EPID)的新技术,以验证剂量率调节跟踪(DRRT)的几何精度。这项技术称为EPID实时跟踪验证(VORTE),可潜在地用于基于MLC的动态肿瘤跟踪的在线和离线质量保证(QA)。方法:将目标的形状和位置作为时间的函数(假定是已知的)投影到EPID平面上。然后,作为时间函数(目标运动)的光圈投影序列将用作参考。动态MLC跟踪的准确性可以通过不使用物理移动体模的情况下,所传输的光束跟随该投影目标运动的程度进行评估。由EPRT检测到的DRRT(光圈运动)控制的光束孔径是时间的函数。将光圈运动与目标运动进行比较,以评估DRRT引入的跟踪误差。使用十个静态场的胶片测量值来测量VORTE的准确性。用于动态肿瘤追踪的VORTE已通过几种目标运动进行了测试,其中包括:(1)上下方向具有不同周期和幅度的刚体二维(2-D)循环运动; (2)上述二维循环运动加循环变形; (3)具有变形和旋转的二维循环运动。对于每个目标运动,在连续采集模式下使用EPID在约8 Hz的频率下获取DRRT产生的受控光圈运动。根据EPID测量所有捕获帧中的叶子位置,并将其与预期位置进行比较。对于肿瘤运动的四个模式中的每一个,计算来自所有帧的所有叶子的2mm标准的通过率。此外,针对所有三种情况,计算了设计光束和传输光束之间的孔径质心的均方根(RMS)偏差。结果:与薄膜测量结果相比,通过VORTE确定MLC叶片位置的精度为0.5 mm(1个标准偏差)。使用DRRT,对于所有采集的帧,使用2毫米标准的通过率对于2D位移为100%,对于2D位移有变形为99%,对于2D位移结合变形和变形为88%。回转。二维位移的RMS偏差为0.6毫米,带变形的二维位移的RMS偏差为1.0毫米,结合变形和旋转的二维位移的RMS偏差为1.1毫米。结论:VORTE可以测量基于MLC的肿瘤追踪的准确性,而无需使用移动体模。此外,它可以用于复杂的目标运动(即,将二维位移与变形和旋转结合在一起),而这些运动很难用物理运动体模创建。因此,本研究说明的VORTE和新颖的QA过程在验证实时肿瘤追踪方面具有巨大潜力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号